Twenty-eight Suffolk-sired (Sx) and 28 Finnsheep-sired (Fx) lambs were implanted with either 0 or 12 mg zeranol. Zeranol significantly increased average daily gain over that of controls. Serum taken at biweekly intervals for 6 weeks was assayed for insulin, somatomedinlike activity (Sm) and fibroblast proliferative activity (FPA). Insulin appeared to increase with time, hut there were no consistent time changes for FPA or Sm. Serum insulin concentration was higher (P<.05) in implanted lambs than in controls (33.4 vs 25.6/aU/ml). Unlike insulin, serum Sm and FPA were not affected by zeranol implantation, and, thus, these serum factors appeared not to be involved in zeranolstimulated growth. Sm was higher in the faster growing Sx lambs than in the slower growing Fx lambs. Thus, serum Sm activity may be involved in normal regulation of growth.
Introduction
Zeranol, a resorcylic acid lactone, has been shown to increase the rate and efficiency of gain by lambs (Wilson et al., 1972) . The mechanism(s) by which zeranol produces its anabolic effect has not been conclusively determined. Serum growth hormone (GH) and insulin, both anabolic hormones, were increased by zeranol implantation in lambs (Olsen et al., 1977) . Chronic exposure to zeranol, through i Authorized for publication as Paper No. 5751 in the Journal Set. of the Pennsylvania Agr. Exp. Sta.
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4Present address: Dept. of Foods and Nutrition, Univ. of Georgia, Athens 30602. implantation, was necessary to increase serum concentrations of both GH and insulin.
Many of the anabolic actions of GH are now believed to be mediated by somatomedin (Sm) (Chochinov and Daughaday, 1976) . Sm is not one peptide, but actually a family of GHdependent peptides (Van Wyk et al., 1974) . Three similar peptides, called Sm A, B and C, have been isolated from sera (Van Wyk et al., 1969; Hall and Uthne, 1971; Fryklund et al., 1974a) . The acid-ethanol-soluble portion of nonsuppressible insulin-like activity (NSILA-S) and multiplication stimulating activity (MSA), a peptide isolated from media conditioned by liver cells, are often classified as Sm (Van Wyk et al., 1974) .
At least two other growth factors have been shown to support in vitro cell growth. Fibroblast growth factor (FGF), isolated from the bovine pituitary, stimulated growth of cultured myoblasts (Gospodarowicz, 1975; Gospodarowicz et al., 1976) . Epidermal growth factor (EGF), isolated from the mouse submaxillary gland, promoted growth of epithelial cells in vitro and in vivo (Cohen, 1962 (Cohen, , 1965 . In vivo functions for FGF and EGF have not been demonstrated. All the growth factors mentioned stimulated cell growth in various types of cultured fibroblasts (Pierson and Temin, 1972; Fryklund et al., 1974b; Carpenter et al., 1975; Zapf et al., 1975) . Presumably, fibroblast proliferative activity (FPA) of serum is a function of the cumulative action of these mitogenic factors. The purpose of this study was to determine the effect of breed of lamb and zeranol implantation on serum insulin, Sm and FPA. were assigned to one of eight treatment groups in a three-factor, completely randomized design. Factors were breed of sire, growth rate and implant. Body weights of the lambs were taken at birth and 1 week before the initiation of the study, and the animals were classified as fast or slow growers on the basis of gain during this pretrial period. One-half the lambs in each group were implanted with 12 mg of zeranol s at the base of the ear. The lambs were implanted at an average age of 90 clays (30.5 kg).
Materials and Methods

Fifty
The animals were penned by treatment group and fed ad libitum. The diet fed and other management procedures, including procedures for carcass evaluation, have been reported previously (Wiggins et al., 1979) . Body weights were taken biweekly. Blood samples were taken by jugular puncture at approximately 0830 each day, which was 2 hr after the morning feeding. Blood was sampled at this time to minimize the influence of possible diurnal variations of serum constituents. Blood was allowed to clot at room temperature and clots were removed by centrifugation. Serum was stored at -80 C until assayed.
FPA of serum was determined by the measurement of 3H-methylthymidine6 uptake in human lung (WI-38) fibroblasts. Assay procedures are described elsewhere (Olsen et al., 1980a) . Sm-like activity of serum was determined by 3s SO4 uptake in chick epiphyseal cartilage according to procedures described previously (Gahagan, 1980; Olsen et al., 1980b) . Insulin was determined by double antibody radioimmunoassay according to procedures described previously (Olsen et aL, 1977) .
Data were subjected to analysis of variance for a completely randomized design (Steel and Torrie, 1960) . Mean separation was by Duncan's Least Significant Difference test (Waller and Duncan, 1969) .
Results and Discussion
Detailed information on measurements of body weight gain, carcass characteristics and certain endocrine-histological traits of these lambs has been reported previously (Wiggins et al., 1979) . In general, Sx-sired lambs were heavier than Fx-sired lambs at the beginning of s Supported in part by IMC Chemical Corp., Inc. 6 New England Nuclear. the trial and maintained a faster growth rate throughout the trial. Zeranol-implanted lambs exhibited greater rates of gain than nonqmplanted lambs. With respect to slaughter and carcass traits, Sx lambs had heavier carcasses, higher mean conformation and leg scores and higher cutahility percentages than the Fx lambs. Sx lambs had less kidney fat and larger longissimus muscle areas. Zeranol implantation had no effect on carcass characteristics. Pretrial growth rate did not contribute significantly to the variation in average daily gain during the trial. This variable was subsequently dropped from the analysis of the variations, 'and the values were pooled to give 14 replications per treatment mean.
The possible mode(s) of action of anabolic agents, including zeranol, have been reviewed (Preston, 1975; Trenkle, 1976; Buttery et al., 1978; Heitzman, 1979) and, in all cases, the possibility has been discussed that the endocrine system may be involved in the growthpromoting properties of anabolic agents. Measurements of endocrine-histologic characteristics of the lambs in the present study (Wiggins et al., 1979) , along with the serum concentrations of insulin (table 1), serum fihroblast proliferative activity (table 2) and serum Sm-like activity (table 3) , were intended to add to our understanding of the causes of differences in growth rate (Sx versus Fx and implant versus nonimplant).
Serum insulin (table 1) was similar for Sx and Fx lambs, and in both breeds insulin increased after initiation of the trial, possibIy because of the high concentrate diet fed. Zeranol implantation increased (P<.05) concentration of serum insulin. Although some studies have shown blood insulin to be unchanged (Borger et al., 1973) or depressed slightly (Wiggins et aL, 1976) , others (Sharp and Dyer, 1970; Olsen et al., 1977) have indicated increased blood insulin concentrations in zeranol-implanted animals. Differences in time between implantation and blood sampling may account for the variation in insulin response. Increased serum insulin may also be involved in the anabolic response of other growth promotants (Trenkle, 1976) . The enhancement by insulin of ribosome activity and uptake of amino acids by mammalian muscle cells (Young, 1976) would be consistent with elevated insulin concentrations in zeranolimplanted animals. The increase in serum insulin may have been a result of increased Davis et al., 1970) , and zeranol implantation has increased blood GH (Borger et al., 1973; Wiggins et al., 1976) and pituitary weight (Rothenbacher et al., 1975; Wiggins et al.. 1976) . Unfortunately, serum GH measurements were not taken in the present study. But the zeranol-implanted lambs had higher pituitary weights (.88 vs .66 g) than nonimplanted lambs (Wiggins et al., 1979) , and thus it is possible that serum GH may have been inCreased by zeranol im plantation. The assay for serum FPA was intended as an estimate of the collective activities of several serum "growth factors," including Sm activity. There were no breed or implant effects on serum FPA (table 2). As discussed in another report (Olsen et al., 1980b) , it is possible that the use of other cell types (e.g., myogenic cells) in the same assay system might have given different results. This possibility is being tested.
Serum Sm-like activity (table 3) was not influenced by zeranol implantation. Thus, altered Sm activity was not associated with zeranol-stimulated growth in this study. It is possible that increased corticosteroids in implanted lambs may have prevented increased Sm activity. Corticosteroids have been shown to inhibit Sm secretion and activity (Wiedeman et al., 1977) . Although higher blood cortisol was reported in zeranol-implanted wethers than in DES-implanted wethers (Wiggins et al., 1976) , cortisol in zeranol-implanted lambs was only slightly higher than that in control lambs. There is indirect evidence, however, that zeranol may cause an increase in glucocorticoid status.
Histological measurements revealed increased adrenal weight and increased number of ACrH secretory cells (Rothenbacher et al., 1975 ; Wiggins et al., 1976) in zeranol-implanted lambs.
Serum Sm (table 3) was higher (P<.05) in the faster growing Sx-sired lambs than in the slower growing Fx-sired lambs. Lund-Larsen et al. (1977) found Sm to be positively correlated to rate of gain and linear growth in Red Danish bulls. Sm was also related to growth in swine selected for body weight gain (Lund-Larsen and Bakke, 1975) . We have also reported a positive association between serum Sm-like activity and relative weight gain in lambs between 2 and 18 weeks of age (Olsen et al., 1980b) . As would be expected, rate of gain of the lambs in the present study was greater during the early part of the feeding period than during the latter stages (Wiggins et al., 1979) . Furthermore, the difference between 14-day average daily gains (ADG) of Sx and Fx lambs (Sx = .45, Fx = .31) was greater than the difference in 46-day ADG (Sx --.33, Fx = .26). It is noteworthy that the difference in serum Sm between Sx control and Fx control lambs was greater at preimplant and decreased until 6 weeks (table 3). These observations provide further evidence that serum Sm activity may be involved in the normal regulation of growth.
Although this article deals mainly with the possible role of the endocrine system and serum growth factors in zeranol-stimulated growth, other equally important mechanisms may exist that help explain the mode of action. For example, specific receptors (Roth et al., 1979) on target cells may be involved. Several recent reports have discussed the interaction of the zeranol molecule with receptor sites on body tissue cells (Peck and Chesworth, 1977; Katzenellenbogen et al., 1979) . We are currently evaluating results of studies in which we added zeranol to in vitro cell cultures to determine whether it has a direct stimulatory action on cellular growth in vitro.
In summary, weight gain was increased by zeranol implantation in Sx-sired and Fx-sired lambs. Serum insulin was increased by implantation, but Sm activity and FPA were not. Sx-sired lambs were higher in Sm than Fx-sired lambs, a finding consistent with their higher ADG. 
